Ultragenyx Pharmaceutical Inc. (RARE)

Ultragenyx Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,534	3,882	3,926	3,248	5,732	9,158
Market Cap Growth	-1.13%	-1.13%	20.88%	-43.33%	-37.41%	271.16%
Enterprise Value	3,699	3,991	4,355	3,149	5,183	8,768
Last Close Price	37.64	42.07	47.82	46.33	84.09	138.43
PS Ratio	6.08	6.93	9.04	8.94	16.31	33.79
PB Ratio	13.64	14.80	14.26	9.21	6.21	7.93
P/TBV Ratio	108.49	119.17	60.65	21.95	7.67	9.36
EV/Sales Ratio	6.60	7.12	10.03	8.67	14.75	32.35
Debt / Equity Ratio	3.47	3.47	3.39	2.57	0.43	0.33
Asset Turnover	0.37	0.37	0.29	0.24	0.21	0.19
Inventory Turnover	19.62	19.62	22.84	34.15	35.05	34.01
Quick Ratio	2.13	2.13	2.32	3.04	4.33	6.51
Current Ratio	2.37	2.37	2.61	3.38	4.72	6.83
Return on Equity (ROE)	-211.71%	-211.71%	-193.22%	-110.96%	-43.72%	-20.64%
Return on Assets (ROA)	-22.37%	-22.37%	-23.43%	-26.44%	-14.54%	-14.25%
Return on Capital (ROIC)	-28.12%	-28.12%	-28.81%	-31.49%	-16.72%	-16.22%
Earnings Yield	-16.10%	-14.66%	-15.45%	-21.78%	-7.92%	-2.04%
FCF Yield	-11.93%	-10.86%	-13.22%	-15.29%	-7.18%	-1.92%
Buyback Yield / Dilution	-23.11%	-23.11%	-5.19%	-3.13%	-11.42%	-7.54%

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q